We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Dr. Cowen has 20 years of pharmaceutical/biotech experience with a broad background spanning Business Development, Finance, R&D Portfolio Management, Marketing, and Sales. He has also worked across the spectrum including large pharma, mid-sized pharma and small companies.
Currently, Dr. Cowen is CEO at ImmunoMet Therapeutics Inc., a VC funded company utilizing cellular metabolism to develop novel anti-tumor and immuno-metabolism therapies. Dr. Cowen joined ImmunoMet in Nov. 2016 as COO as was promoted to CEO a year later.
Dr. Cowen currently serves on the Board of Directors of INCON, a public Korean company that invests in healthcare companies.
Dr. Cowen originally trained as research scientist and was an NIH Postdoctoral Fellow at the Univ. of Pennsylvania. He holds a BA in Physics with high honors from Brandeis Univ., a PhD in Biophysics from the University of Illinois and an MBA in Strategy and Finance from Carnegie Mellon Univ.
This speaker's sessions: